Rapid Micro Biosystems (RPID)

• Market cap: $138M
• 1 day: -12.30%
• 5 days: -9.83%
• 1 month: 129.29%
• 3 months: 189.19%
• 6 months: 282.19%
• Year to date: 226.52%
• 1 year: 241.49%
• 5 years: -85.00%
• 10 years: -85.00%
• Sector: Industrials
• Industry: Laboratory Analytical Instruments

About: Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.

Employees: 193

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

100% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 3

0% more funds holding

Funds holding: 19 [Q3] → 19 (+0) [Q4]

15.87% less ownership

Funds ownership: 47.54% [Q3] → 31.67% (-15.87%) [Q4]

32% less capital invested

Capital invested by funds: $15.9M [Q3] → $10.8M (-$5.16M) [Q4]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q3] → 1 (-1) [Q4]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $8 149% upside
• Avg. target: $8 149% upside
• High target: $8 149% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Keybanc Paul Knight 33% 1-year accuracy 3 / 9 met price target

149% upside $8

Overweight Initiated

12 Feb 2025